ARK Invest's position in DRTS, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| IZRL | 135,232 | $1.8M | 1.51% | #36 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | IZRL | Sell | Trimmed | 16,227 | $217K |
| 2026-10-15 | IZRL | Sell | Trimmed | 28,910 | $380K |
| 2026-07-16 | IZRL | Sell | Trimmed | 89,538 | $1.1M |
| 2026-04-16 | IZRL | Sell | Trimmed | 15,048 | $120K |
| 2026-01-15 | IZRL | Buy | Added | 275,534 | $2.1M |
| 2026-01-14 | IZRL | Buy | New position | 5,505 | $41K |
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors…
See DRTS's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open DRTS on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.